Verzenio 100 MG tablet UU 14S
Ended Awarded
- Contract number
- SPE2DB25FUBVY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,020
Award facts
- Contract value 100% obligated
- $10,019.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,019.84 to AmerisourceBergen Drug Corp for the supply of Verzenio 100 mg tablets (14-count unit of use packaging) with a firm fixed price structure. This non-competitive delivery order, issued on May 30, 2025, is scheduled for completion by June 2, 2025, and will be fulfilled from the vendor's facilities in Conshohocken, Pennsylvania. Verzenio is a prescription oncology medication used in the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, reflecting the critical nature of cancer therapeutics within the federal medical supply chain.
This delivery order derives from AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical prime vendor agreement extending through December 2026. As a leading pharmaceutical distributor serving federal healthcare systems including the Defense Health Agency and U.S. Coast Guard, AmerisourceBergen Drug Corp maintains a robust contract portfolio delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's selection for this oncology medication delivery demonstrates its continued role as a critical vendor supporting military healthcare programs and beneficiaries requiring access to advanced pharmaceutical treatments.
Quick answers
Who was awarded contract SPE2DB25FUBVY?
SPE2DB25FUBVY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FUBVY worth?
The government has obligated $10,020 on SPE2DB25FUBVY.
Is contract SPE2DB25FUBVY an order under another contract?
Yes. SPE2DB25FUBVY is a delivery order under SPE2DB25D3306, an indefinite delivery contract.
Was contract SPE2DB25FUBVY competed?
The extent of competition for SPE2DB25FUBVY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award